Seguir
Peter Caravan
Peter Caravan
Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging (i3), MGH, Harvard
Email confirmado em nmr.mgh.harvard.edu
Título
Citado por
Citado por
Ano
Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications
P Caravan, JJ Ellison, TJ McMurry, RB Lauffer
Chem. Rev 99, 2293-2352, 1999
54871999
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents
P Caravan
Chemical Society Reviews 35 (6), 512-523, 2006
17022006
The chemistry of contrast agents in medical magnetic resonance imaging
AS Merbach, L Helm, É Tóth
John Wiley & Sons, 2013
16922013
Chemistry of MRI contrast agents: current challenges and new frontiers
J Wahsner, EM Gale, A Rodríguez-Rodríguez, P Caravan
Chemical reviews 119 (2), 957-1057, 2018
11852018
Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition
S Aime, P Caravan
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
6232009
Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium‐ and manganese‐based T1 contrast agents
P Caravan, CT Farrar, L Frullano, R Uppal
Contrast media & molecular imaging 4 (2), 89-100, 2009
6062009
The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates
P Caravan, NJ Cloutier, MT Greenfield, SA McDermid, SU Dunham, ...
Journal of the American Chemical Society 124 (12), 3152-3162, 2002
5382002
Primer on gadolinium chemistry
AD Sherry, P Caravan, RE Lenkinski
Journal of magnetic resonance imaging: an official journal of the …, 2009
4692009
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action
P Caravan
Accounts of chemical research 42 (7), 851-862, 2009
4442009
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ...
Hepatology 59 (4), 1577-1590, 2014
3462014
Reaction chemistry of BMOV, bis (maltolato) oxovanadium (IV), a potent insulin mimetic agent
C Orvig, P Caravan, L Gelmini, N Glover, FG Herring, H Li, JH McNeill, ...
Journal of the American Chemical Society 117 (51), 12759-12770, 1995
3341995
A manganese alternative to gadolinium for MRI contrast
EM Gale, IP Atanasova, F Blasi, I Ay, P Caravan
Journal of the American Chemical Society 137 (49), 15548-15557, 2015
3182015
Collagen-targeted MRI contrast agent for molecular imaging of fibrosis
P Caravan, B Das, S Dumas, FH Epstein, PA Helm, V Jacques, S Koerner, ...
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH- 46 (43), 8171, 2007
2792007
Clinical magnetic resonance imaging
RR Edelman, JR Hesselink
(No Title), 2006
2572006
EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus
K Overoye-Chan, S Koerner, RJ Looby, AF Kolodziej, SG Zech, Q Deng, ...
Journal of the American Chemical Society 130 (18), 6025-6039, 2008
2532008
Gut microbiota is critical for the induction of chemotherapy-induced pain
S Shen, G Lim, Z You, W Ding, P Huang, C Ran, J Doheny, P Caravan, ...
Nature neuroscience 20 (9), 1213-1216, 2017
2192017
Contrast agents for MRI: 30+ years and where are we going?
VC Pierre, MJ Allen, P Caravan
JBIC Journal of Biological Inorganic Chemistry 19, 127-131, 2014
2002014
Postinfarction Myocardial Scarring in Mice: Molecular MR Imaging with Use of a Collagen-targeting Contrast Agent1
PA Helm, P Caravan, BA French, V Jacques, L Shen, Y Xu, RJ Beyers, ...
Radiology 247 (3), 788-796, 2008
1932008
Enzyme-Activated Gd3+ Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor-Induced Magnetization Enhancement.
AL Nivorozhkin, AF Kolodziej, P Caravan, MT Greenfield, RB Lauffer, ...
Angewandte Chemie (International ed. in English) 40 (15), 2903-2906, 2001
1852001
Bimodal MR-PET agent for quantitative pH imaging
L Frullano, C Catana, T Benner, AD Sherry, P Caravan
Angewandte Chemie (International ed. in English) 49 (13), 2382, 2010
1832010
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20